Displaying drugs 7826 - 7850 of 9970 in total
(S,R)-fidarestat
Experimental
Tryptophanamide
Experimental
SNS-032
Investigational
Gavestinel
Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo.
Investigational
CGS-27023
Experimental
N-oxo-2-(phenylsulfonylamino)ethanamide
Experimental
N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE
Experimental
Cilengitide
Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.
Investigational
Apitolisib
Apitolisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, and Endometrial Carcinoma, among others.
Investigational
Apratastat
Tmi 005 is under investigation in clinical trial NCT00095342 (Study Evaluating TMI-005 in Active Rheumatoid Arthritis).
Investigational
1-naphthaleneacetic acid
Experimental
Displaying drugs 7826 - 7850 of 9970 in total